Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men - PubMed (original) (raw)
Comparative Study
. 2006 Dec;63(12):1386-95.
doi: 10.1001/archpsyc.63.12.1386.
Affiliations
- PMID: 17146013
- DOI: 10.1001/archpsyc.63.12.1386
Comparative Study
Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men
Isabelle Boileau et al. Arch Gen Psychiatry. 2006 Dec.
Abstract
Context: In animals, repeated exposure to stimulant drugs leads to an enhanced drug-induced psychomotor response and increased dopamine release. This phenomenon, known as sensitization, may confer vulnerability to drug addiction or drug-induced psychosis in humans. A similar phenomenon, referred to as endogenous sensitization, is also believed to play a role in the emergence of positive symptoms in patients with schizophrenia.
Objective: To determine whether behavioral and neurochemical sensitization occur in healthy individuals after limited exposure to amphetamine in the laboratory.
Design: Open-label, 1-year follow-up of repeated amphetamine administration in healthy volunteers.
Setting: Department of Psychiatry, McGill University, and McConnell Brain Imaging Center, Montreal Neurological Institute.
Participants: Ten healthy men (mean +/- SD age, 25.8 +/- 1.8 years).
Intervention: Three single doses of amphetamine (dextroamphetamine sulfate, 0.3 mg/kg by mouth) were administered on days 1, 3, and 5.
Main outcome measures: Using positron emission tomography and [11C]raclopride, we measured dopamine release in response to amphetamine on the first exposure (day 1) and 14 days and 1 year after the third exposure.
Results: The initial dose of amphetamine caused dopamine release in the ventral striatum (a reduction in [11C]raclopride binding). Consistent with a sensitization-like phenomenon, 14 and 365 days after the third dose of amphetamine there was a greater psychomotor response and increased dopamine release (a greater reduction in [11C]raclopride binding), relative to the initial dose, in the ventral striatum, progressively extending to the dorsal caudate and putamen. A high novelty-seeking personality trait and self-rating assessments indicating impulsivity predicted proneness to sensitization.
Conclusions: Sensitization to stimulants can be achieved in healthy men in the laboratory. This phenomenon is associated with increased dopamine release and persists for at least 1 year.
Similar articles
- Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
Koochesfahani KM, de la Fuente-Fernández R, Sossi V, Schulzer M, Yatham LN, Ruth TJ, Blinder S, Stoessl AJ. Koochesfahani KM, et al. Mov Disord. 2006 Jul;21(7):970-5. doi: 10.1002/mds.20857. Mov Disord. 2006. PMID: 16570297 Clinical Trial. - Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM. Volkow ND, et al. Arch Gen Psychiatry. 2007 Aug;64(8):932-40. doi: 10.1001/archpsyc.64.8.932. Arch Gen Psychiatry. 2007. PMID: 17679638 - Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers.
Booij L, Welfeld K, Leyton M, Dagher A, Boileau I, Sibon I, Baker GB, Diksic M, Soucy JP, Pruessner JC, Cawley-Fiset E, Casey KF, Benkelfat C. Booij L, et al. Transl Psychiatry. 2016 Feb 23;6(2):e740. doi: 10.1038/tp.2016.6. Transl Psychiatry. 2016. PMID: 26905412 Free PMC article. - PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
Nader MA, Czoty PW. Nader MA, et al. Am J Psychiatry. 2005 Aug;162(8):1473-82. doi: 10.1176/appi.ajp.162.8.1473. Am J Psychiatry. 2005. PMID: 16055768 Review. - Measuring amphetamine-induced dopamine release in humans: A comparative meta-analysis of [11 C]-raclopride and [11 C]-(+)-PHNO studies.
Caravaggio F, Porco N, Kim J, Torres-Carmona E, Brown E, Iwata Y, Nakajima S, Gerretsen P, Remington G, Graff-Guerrero A. Caravaggio F, et al. Synapse. 2021 May;75(5):e22195. doi: 10.1002/syn.22195. Epub 2021 Feb 1. Synapse. 2021. PMID: 33471400 Review.
Cited by
- Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder.
Nieto SJ, Grodin EN, Ray LA. Nieto SJ, et al. Behav Brain Res. 2024 Apr 27;464:114926. doi: 10.1016/j.bbr.2024.114926. Epub 2024 Feb 29. Behav Brain Res. 2024. PMID: 38431152 Free PMC article. - Mesocorticolimbic function in cocaine polydrug users: A multimodal study of drug cue reactivity and cognitive regulation.
Scala SG, Kang MS, Cox SML, Rosa-Neto P, Massarweh G, Leyton M. Scala SG, et al. Addict Biol. 2024 Jan;29(1):e13358. doi: 10.1111/adb.13358. Addict Biol. 2024. PMID: 38221806 Free PMC article. - Amphetamine Induces Sex-Dependent Loss of the Striatal Dopamine Transporter in Sensitized Mice.
Bagalkot T, Sorkin A. Bagalkot T, et al. eNeuro. 2024 Jan 29;11(1):ENEURO.0491-23.2023. doi: 10.1523/ENEURO.0491-23.2023. Print 2024 Jan. eNeuro. 2024. PMID: 38164591 Free PMC article. - Effects of chronic methamphetamine exposure on rewarding behavior and neurodegeneration markers in adult mice.
Davis DL, Metzger DB, Vann PH, Wong JM, Shetty RA, Forster MJ, Sumien N. Davis DL, et al. Psychopharmacology (Berl). 2023 Jun;240(6):1343-1358. doi: 10.1007/s00213-023-06374-y. Epub 2023 May 2. Psychopharmacology (Berl). 2023. PMID: 37127834 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources